Price
No data yet.
Social Signal Score
Analyst Ratings
2 analystsRevenue
$5.23M+101.31%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- R. Stephen Harshbarger
- Sector
- Industrials
- Industry
- Industrial - Machinery
- Employees
- 84
- Beta
- -0.02
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 9.53
Financials
Revenue
$5.23M+101.3%Net Income
$366.3K+487.6%EBITDA
$622.0K+209.0%Free Cash Flow
$1.14M+203.1%EPS (diluted)
$0.02+387.8%Shares Outstanding (diluted)
15.81M+5.1%Operating Expenses
$2.39MCash & Debt
$17.76MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $20.91M | $1.81M | $0.11 |
| 2025 | $20.50M | $1.27M | $0.08 |
| 2024 | $19.70M | $1.44M | $0.09 |
| 2023 | $15.06M | $635.9K | $0.04 |
| 2022 | $17.13M | $2.54M | $0.16 |
| 2021 | $14.83M | $1.12M | $0.07 |
| 2020 | $15.35M | $1.11M | $0.07 |
| 2019 | $11.61M | $161.6K | $0.01 |
| 2018 | $11.01M | $368.2K | $0.02 |
| 2017 | $9.72M | $95.7K | $0.01 |
| 2016 | $11.83M | $547.7K | $0.04 |
| 2015 | $10.85M | $606.1K | $0.04 |
| 2014 | $10.28M | $484.5K | $0.03 |
| 2013 | $9.54M | $132.3K | $0.01 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from SOTK's reported EPS growth of 20.3% a year over 13 years.
- EPS in 5 years
- $0.29
- Implied price
- $11.29
- Return from $3.96
- 23.3% a year
To earn 15.0% a year on these assumptions you'd need to buy at $5.61 — today's price is already 29.4% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 27 | 33 | 39 | 45 | 51 |
|---|---|---|---|---|---|
| 10.3% | 5.0% | 9.3% | 13.1% | 16.3% | 19.3% |
| 15.3% | 9.8% | 14.3% | 18.2% | 21.6% | 24.7% |
| 20.3% | 14.6% | 19.3% | 23.3% | 26.9% | 30.1% |
| 25.3% | 19.3% | 24.2% | 28.4% | 32.2% | 35.5% |
| 30.3% | 24.1% | 29.2% | 33.6% | 37.4% | 40.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70+40.00%Social Signal Score
Mentions (9)
- Newsseekingalpha.com·37d ago·Positive
…seeing strong growth in medical applications, and a solid sales outlook of modest growth or flat sales for the rest of the FY. Customer concentration remains high at SOTK, with 52% of sales from two customers. In general, products need to get validated for momentum to continue. On the other hand, the success in higher ASP sales and in the sorts of things sold in the medical vertical could lend itself to follow-on sales.
View source ↗ - Newsseekingalpha.com·39d ago·Positive
Sono-Tek Corporation (SOTK) Q2 2027 Earnings Call Transcript Sono-Tek Corporation ( SOTK ) Q2 2027 Earnings Call October 14, 2026 10:30 AM EDT Company Participants Christopher Coccio - Executive Chairman R. Harshbarger - President, CEO & Director Stephen Bagley - Chief Financial Officer Conference Call Participants Kirin Smith - ProActive Capital Group, LLC Bill Nicklin Richard Ryan - Oak Ridge Financial Services Group Inc., Research Division Edward Jackson - Northland Capital Markets, Research …
View source ↗ - Newsmarketbeat.com·39d ago·Neutral
Sono-Tek Q2 Earnings Call Highlights Sono-Tek NASDAQ: SOTK reported fiscal 2027 first-half revenue growth, wider gross margins and higher profitability, led by a sharp increase in medical-market sales and demand for higher-value production systems. Management also highlighted recent order activity that it said provides increased visibility into fiscal 2028.
View source ↗ - Newszacks.com·39d ago·Negative
Sono-Tek Corporation (SOTK) Misses Q2 Earnings and Revenue Estimates Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.03 per share a year ago.
View source ↗ - Newsglobenewswire.com·39d ago·Positive
…ge Orders Recent New Record Orders Significantly Increases Revenue Visibility for FY 28 MILTON, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of precision ultrasonic coating systems, today reported financial results for the second quarter and first half of fiscal year 2027, ended August 31, 2026.
View source ↗ - Newsglobenewswire.com·46d ago·Neutral
Sono-Tek Announces Fiscal Second Quarter and First Half 2027 Earnings Conference Call MILTON, N.Y., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that the Company will hold a conference call to discuss its fiscal second quarter and first half 2027 financial results, ended August 31, 2026, on Wednesday, October 14, 2026 at 10:30 am ET.
View source ↗ - Newszacks.com·52d ago·Neutral
SonoTek (SOTK) Moves 18.5% Higher: Will This Strength Last? SonoTek (SOTK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
View source ↗ - Newsglobenewswire.com·53d ago·Neutral
…in Company History Record Orders Significantly Increase Fiscal 2028 Revenue Visibility MILTON, N.Y., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has received three purchase orders totaling approximately $7.19 million from an existing customer in the clean energy sector.
View source ↗ - Newsprismmediawire.com·103d ago·Neutral
Sono-Tek Receives Record Order of Over $3.6 Million for a Single Integrated Production Line Largest Single Production Line Order in Company History Will Support High-Volume Medical Diagnostic Manufacturing MILTON, N.Y., Aug.
View source ↗
Earnings
Tue, Jan 12(in 7 weeks)
Consensus estimate $0.01 per share
Typical surprise +50.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Oct 14$0.02 vs $0.04miss
- Wed, Jul 8$0.05 vs $0.05beat
- Thu, May 28$0.03 vs $0.02beat
- Tue, Jan 13$0.02 vs $0.03miss
- Tue, Oct 14$0.03 vs $0.02beat
- Thu, Jul 10$0.03 vs $0.02beat
Estimates and results for SOTK via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SOTK officers and directors.
- Bought
- $10k
- Sold
- $266k
1 trade
20 trades
- Bagley Stephen Jamessold
- Bagley Stephen Jamessold
- Bagley Stephen Jamessold
- Coccio Christopher Lsold
- Lawal Adeniyibought
- Coccio Christopher Lsold
- Coccio Christopher Lsold
- Coccio Christopher Lsold
79 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in SOTK.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
